Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

AIMS: At present, an increasing number of studies are trying to determine whether dapagliflozin has a significant effect on the occurrence and development of atherosclerosis in patients with type 2 diabetes mellitus (T2DM), but there is no consensus. In addition, the former meta-analyses, relying on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qian-Long, Zheng, Ting, Li, Sheng-Zhen, Chen, Jin-An, Xie, Zi-Chun, Lai, Jian-Mei, Zeng, Ji-Yuan, Lin, Jin-Ting, Huang, Jia-Shuan, Lin, Min-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908556/
https://www.ncbi.nlm.nih.gov/pubmed/35272683
http://dx.doi.org/10.1186/s13098-022-00810-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908556/
https://www.ncbi.nlm.nih.gov/pubmed/35272683
http://dx.doi.org/10.1186/s13098-022-00810-3

Ejemplares similares